Improvement of Care & Outcome

publications

PRIMARY VS SECONDARY PATIENTS: THE DIABETER EXPERIENCE
P Dekker,D Mul, M De Vries, T Sas, HJ Aanstoot, H Veeze.

Glycaemic control in T1D patients treated from clinical onset in a value-based care center vs. patients transferred from other centers: the DIABETER experience. 13th International Conference on Advanced Technologies and Treatments for Diabetes, 19-22 February 2020, Madrid. Abstract: #628.
FRAMEWORK CONDITIONS FOR SUCCESFUL USE OF TECHNOLOGY IN T1D
Mul D, Aanstoot HJ, Dekker P, de Vries M, Sas T, Veeze HJ.

Improvement of A1C can be obtained in an optimal and enabling setting that combines technology and patient-HCP contacts through data-upload and eHealth. 45th Annual of the International Society for Pediatric and Adolescent Diabetes (ISPAD), Oct 30-Nov 2 2019, Abstract: #O23
TO PUMP OR NOT TO PUMP: CSII DISCONTINUATION AMONG CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
T Sas, C De Jong, M De Vries, P Dekker, HJ Aanstoot, H Veeze, D Mul.

Discontinuation of pump use in children and adolescents with type 1 diabetes. 12th International Conference on Advanced Technologies and Treatments for Diabetes, 20-23 February 2019, Berlin. Abstract: #279.
INCIDENCE OF PEDIATRIC T1DM DOUBLES IN 30 YEARS
Spaans EA, Gusdorf LM, Groenier KH, Brand PL, Veeze HJ, Reeser HM, Bilo HJ, Kleefstra N.

The incidence of type 1 diabetes is still increasing in the Netherlands, but has stabilised in children under five (Young DUDEs-1). Acta Pediatr. 2015;104:626-9.
GLOBAL STUDY COMPARES GLYCEMIC CONTROL RATES
McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA, Hofer S et al.

Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32:1036-50.
INSULIN DOSING CALCULATOR FOR NEW PATIENTS EVALUATED
Mul D, Aanstoot HJ, Simm D, Veeze HJ.

Initial insulin dosage in new onset pediatric diabetes: how to start? Presented at: 8th International Conference on Advanced Technologies and Treatments for Diabetes, 18-21 February 2015, Paris. Abstract: #286.
THYROID PEROXIDASE AUTOIMMUNITY IN T1DM – HOW PREVALENT IS IT?
D. Simm, E.Birnie, D. Mul, H.J. Veeze, H.J. Aanstoot.

Thyroid peroxidase autoimmunity and the effect on thyroid function in children and adolescents with type 1 diabetes. Presented at: 8th International Conference on Advanced Technologies and Treatments for Diabetes, 18-21 February 2015, Paris. Abstract: #376.
FAMILY FACTORS INFLUENCE PATIENT OUTCOMES
Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H, Aman J, Martul P et al.

Are family factors universally related to metabolic outcomes in adolescents with type 1 diabetes? Diabet Med. 2008;25:463-8.
© 2019 Diabeter | Terms of Use | Privacy Statement